Can Circulating Regulatory T Cells Predict Cardiovascular Disease?
- PMID: 27592599
- PMCID: PMC5049994
- DOI: 10.1016/j.ebiom.2016.08.044
Can Circulating Regulatory T Cells Predict Cardiovascular Disease?
Similar articles
-
The Ratio of Regulatory (FOXP3+) to Total (CD3+) T Cells Determined by Epigenetic Cell Counting and Cardiovascular Disease Risk: A Prospective Case-cohort Study in Non-diabetics.EBioMedicine. 2016 Sep;11:151-156. doi: 10.1016/j.ebiom.2016.07.035. Epub 2016 Jul 30. EBioMedicine. 2016. PMID: 27499494 Free PMC article.
-
Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular disease.Diab Vasc Dis Res. 2019 May;16(3):270-280. doi: 10.1177/1479164118817942. Epub 2018 Dec 21. Diab Vasc Dis Res. 2019. PMID: 30574794
-
Editorial: Regulatory T Cell Heterogeneity: Canonical and Non-Canonical Functions.Front Immunol. 2021 Sep 22;12:722563. doi: 10.3389/fimmu.2021.722563. eCollection 2021. Front Immunol. 2021. PMID: 34630397 Free PMC article. No abstract available.
-
The skewed balance between Tregs and Th17 in chronic lymphocytic leukemia.Future Oncol. 2015;11(10):1567-82. doi: 10.2217/fon.14.298. Future Oncol. 2015. PMID: 25963433 Review.
-
Trafficking of FoxP3+ regulatory T cells: myths and facts.Arch Immunol Ther Exp (Warsz). 2007 May-Jun;55(3):151-9. doi: 10.1007/s00005-007-0024-8. Epub 2007 Jun 8. Arch Immunol Ther Exp (Warsz). 2007. PMID: 17557143 Review.
Cited by
-
T cell subsets and functions in atherosclerosis.Nat Rev Cardiol. 2020 Jul;17(7):387-401. doi: 10.1038/s41569-020-0352-5. Epub 2020 Mar 16. Nat Rev Cardiol. 2020. PMID: 32203286 Free PMC article. Review.
-
Innate and adaptive immune cell subsets as risk factors for coronary heart disease in two population-based cohorts.Atherosclerosis. 2020 May;300:47-53. doi: 10.1016/j.atherosclerosis.2020.03.011. Epub 2020 Mar 16. Atherosclerosis. 2020. PMID: 32209232 Free PMC article.
-
Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials.Basic Res Cardiol. 2017 Jan;112(1):3. doi: 10.1007/s00395-016-0592-z. Epub 2016 Nov 23. Basic Res Cardiol. 2017. PMID: 27882430 Free PMC article.
References
-
- Ammirati E., Cianflone D., Banfi M., Vecchio V., Palini A., De Metrio M., Marenzi G., Panciroli C., Tumminello G., Anzuini A., Palloshi A., Grigore L., Garlaschelli K., Tramontana S., Tavano D., Airoldi F., Manfredi A.A., Luigi Catapano A., Danilo Norata G. Circulating CD4+ CD25hiCD127lo regulatory T-cell levels do not reflect the extent or severity of carotid and coronary atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2010;30:1832–1841. - PubMed
-
- Barth S.D., Kaaks R., Johnson T., Katzke V., Gellhaus K., Josephin J., Olek S., Kühn T. The ratio of regulatory (FOXP3+) to Total (CD3+) T cells determined by epigenetic cell counting and cardiovascular disease risk: a prospective case-cohort study in non-diabetics. EBioMedicine. 2016;11:151–156. - PMC - PubMed
-
- Cheng X., Yu X., Ding Y.-J., Fu Q.-Q., Xie J.-J., Tang T.-T., Yao R., Chen Y., Liao Y.-H. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin. Immunol. 2008;127:89–97. - PubMed
-
- Han S., Liu P., Zhang W., Bu L., Shen M., Li H., Fan Y., Cheng K., Cheng H., Li C., Jia G. The opposite-direction modulation of CD4+ CD25+ Tregs and T helper 1 cells in acute coronary syndromes. Clin. Immunol. 2007;124:90–97. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources